231
Views
4
CrossRef citations to date
0
Altmetric
Original Articles

Unbound bilirubin measurements in term and late-preterm infants

ORCID Icon, , , , &
Pages 1532-1538 | Received 16 Jan 2020, Accepted 23 Apr 2020, Published online: 04 May 2020

References

  • Bhutani VK, Stark AR, Lazzeroni LC, et al. Predischarge screening for severe neonatal hyperbilirubinemia identifies infants who need phototherapy. J Pediatr. 2013;162(3):477–482 e1.
  • Gopinathan V, Miller NJ, Milner AD, et al. Bilirubin and ascorbate antioxidant activity in neonatal plasma. FEBS Lett. 1994;349(2):197–200.
  • Stocker R, Yamamoto Y, McDonagh AF, et al. Bilirubin is an antioxidant of possible physiological importance. Science. 1987;235(4792):1043–1046.
  • Watchko JF, Tiribelli C. Bilirubin-induced neurologic damage–mechanisms and management approaches. New Eng J Med. 2013;369(21):2021–2030.
  • Cremer RJ, Perryman PW, Richards DH. Influence of light on the hyperbilirubinaemia of infants. Lancet. 1958;1(7030):1094–1097.
  • Hansen TWR, Maisels MJ, Ebbesen F, et al. Sixty years of phototherapy for neonatal jaundice – from serendipitous observation to standardized treatment and rescue for millions. J Perinatol. 2019;40:180–193.
  • Newman TB, Kuzniewicz MW, Liljestrand P, et al. Numbers needed to treat with phototherapy according to American Academy of Pediatrics guidelines. Pediatrics. 2009;123(5):1352–1359.
  • Ebbesen F, Bjerre JV, Vandborg PK. Relation between serum bilirubin levels >/=450 mumol/L and bilirubin encephalopathy: a Danish population-based study. Acta Paediatr. 2012;101(4):384–389.
  • Wu YW, Kuzniewicz MW, Wickremasinghe AC, et al. Risk for cerebral palsy in infants with total serum bilirubin levels at or above the exchange transfusion threshold: a population-based study. JAMA Pediatr. 2015;169(3):239–246.
  • Maisels MJ, McDonagh AF. Phototherapy for neonatal jaundice. New Eng J Med. 2008;358(9):920–928.
  • Jasprova J, Dal Ben M, Hurny D, et al. Neuro-inflammatory effects of photodegradative products of bilirubin. Sci Rep. 2018;8(1):7444.
  • Cashore WJ, Oh W. Unbound bilirubin and kernicterus in low-birth-weight infants. Pediatrics. 1982;69(4):481–485.
  • Funato M, Tamai H, Shimada S, et al. Vigintiphobia, unbound bilirubin, and auditory brainstem responses. Pediatrics. 1994;93(1):50–53.
  • Ahlfors CE, Wennberg RP, Ostrow JD, et al. Unbound (free) bilirubin: improving the paradigm for evaluating neonatal jaundice. Clin Chem. 2009;55(7):1288–1299.
  • Huber AH, Zhu B, Kwan T, et al. Fluorescence sensor for the quantification of unbound bilirubin concentrations. Clin Chem. 2012;58(5):869–876.
  • Amin SB, Saluja S, Saili A, et al. Auditory toxicity in late preterm and term neonates with severe jaundice. Dev Med Child Neurol. 2017;59(3):297–303.
  • Management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation. Pediatrics. 2004;114(1):297–316.
  • Kleinfeld A, Huber A, Kameyama H, et al. The effect of conjugated bilirubin on measurements of unbound bilirubin using the UBCheck and Arrows UB analyzer methods. Baltimiore, MD: Pediatric Academic Societies Meeting; 2019.
  • Kleinfeld A, Huber A, Hegyi T. Unbound bilirubin measurements by Arrows and UBCheck analyzers. Pediatric Academies Societies Meeting; 2018 May 6; Toronto, CA.
  • Weisiger RA, Ostrow JD, Koehler RK, et al. Affinity of human serum albumin for bilirubin varies with albumin concentration and buffer composition: results of a novel ultrafiltration method. J Biol Chem. 2001;276(32):29953–29960.
  • Bratlid D. How bilirubin gets into the brain. Clin Perinatol. 1990;17(2):449–465.
  • Turkel SB. Autopsy findings associated with neonatal hyperbilirubinemia. Clin Perinatol. 1990;17(2):381–396.
  • Ahlfors CE. Unbound bilirubin associated with kernicterus: a historical approach. J Pediatr. 2000;137(4):540–544.
  • Wennberg RP, Ahlfors CE, Bhutani VK, et al. Toward understanding kernicterus: a challenge to improve the management of jaundiced newborns. Pediatrics. 2006;117(2):474–485.
  • Hanko E. Unbound bilirubin and risk assessment in the jaundiced newborn: possibilities and limitations. Pediatrics. 2006;117(2):526–527.
  • D’Amico AV, Manola J, Loffredo M, et al. 6-Month androgen suppression plus radiation therapy vs radiation therapy alone for patients with clinically localized prostate cancer: a randomized controlled trial. JAMA. 2004;292(7):821–827.
  • Newman TB, Escobar GJ, Gonzales VM, Armstrong MA, et al. Frequency of neonatal bilirubin testing and hyperbilirubinemia in a large health maintenance organization. Pediatrics. 1999;104(5 Pt 2):1198–1203.
  • Martin JA, Hamilton BE, Sutton PD, et al. Births: final data for 2002. Natl Vital Stat Rep. 2003;52(10):1–113.
  • Newman TB, Maisels MJ. Less aggressive treatment of neonatal jaundice and reports of kernicterus: lessons about practice guidelines. Pediatrics. 2000;105(1 Pt 3):242–245.
  • Newman TB, Liljestrand P, Jeremy RJ, et al. Outcomes among newborns with total serum bilirubin levels of 25 mg per deciliter or more. New Eng J Med. 2006;354(18):1889–1900.
  • Ip S, Lau J, Chung M, et al. Hyperbilirubinemia and kernicterus: 50 years later. Pediatrics. 2004;114(1):263–264.
  • Newman TB, Wickremasinghe AC, Walsh EM, et al. Retrospective cohort study of phototherapy and childhood cancer in Northern California. Pediatrics. 2016;137(6):e20151353.
  • Wickremasinghe AC, Kuzniewicz MW, Grimes BA, et al. Neonatal phototherapy and infantile cancer. Pediatrics. 2016;137(6):e20151353.
  • Hegyi T, Kleinfeld A, Huber A, et al. Effects of soybean lipid infusion on unbound free fatty acids and unbound bilirubin in preterm infants. J Pediatr. 2017;184:45–50 e1.
  • Jacobsen J. Binding of bilirubin to human serum albumin – determination of the dissociation constants. FEBS Lett. 1969;5(2):112–114.
  • Watchko JF, Tiribelli C. Bilirubin-induced neurologic damage. N Engl J Med. 2014;370(10):979.
  • Ahlfors CE, Parker AE. Bilirubin binding contributes to the increase in total bilirubin concentration in newborns with jaundice. Pediatrics. 2010;126(3):e639–43.
  • van Imhoff DE, Dijk PH, Weykamp CW, et al. Measurements of neonatal bilirubin and albumin concentrations: a need for improvement and quality control. Eur J Pediatr. 2011;170(8):977–982.
  • Schmid R, Hammaker L. Metabolism and disposition of C14-bilirubin in congenital nonhemolytic jaundice. J Clin Investigat. 1963;42:1720–1734.
  • Nakamura H, Yonetani M, Uetani Y, et al. Determination of serum unbound bilirubin for prediction of kernicterus in low birthweight infants. Acta Paediatr Jpn. 1992;34(6):642–647.
  • Jacobsen J, Wennberg RP. Determination of unbound bilirubin in the serum of newborns. Clin Chem. 1974;20(7):783.
  • Wennberg RP. Measuring free bilirubin: the clinical perspective. Clin Chem. 2012;58(5):811–813.
  • Huber AH, Hegyi T, Kleinfeld AM. Free fatty acids produced from intralipid and sulfisoxazole displace similar amounts of bilirubin from albumin. Vancouver, CA: Pediatric Academic Societies; 2014.
  • Kuzniewicz MW, Escobar GJ, Newman TB. Impact of universal bilirubin screening on severe hyperbilirubinemia and phototherapy use. Pediatrics. 2009;124(4):1031–1039.
  • Wickremasinghe AC, Kuzniewicz MW, McCulloch CE, et al. Efficacy of subthreshold newborn phototherapy during the birth hospitalization in preventing readmission for phototherapy. JAMA Pediatr. 2018;172(4):378–385.
  • Reshad M, Ravichander B, Raghuraman TS. A study of cord blood albumin as a predictor of significant neonatal hyperbilirubinemia in term and preterm neonates. Int J Res Med Sci. 2016;4(3):887–890.
  • Xiong T, Qu Y, Cambier S, et al. The side effects of phototherapy for neonatal jaundice: what do we know? What should we do? Eur J Pediatr. 2011;170(10):1247–1255.
  • Newman TB, Wu YW, Kuzniewicz MW, et al. Childhood seizures after phototherapy. Pediatrics. 2018;142(4):e20180648.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.